Patterns of prostate-specific antigen (PSA) testing in Australian men: the influence of family history

被引:12
|
作者
McDowell, Michelle E. [1 ]
Occhipinti, Stefano [1 ]
Gardiner, Robert A. [2 ,3 ]
Chambers, Suzanne K. [2 ]
机构
[1] Griffith Univ, Sch Appl Psychol, Griffith Hlth Inst, Mt Gravatt, Qld 4111, Australia
[2] Univ Queensland, Clin Res Ctr, Brisbane, Qld 4072, Australia
[3] Royal Brisbane Hosp, Dept Urol, Brisbane, Qld, Australia
关键词
prostate cancer; family history; early detection; CANCER; RELATIVES; RISK; METAANALYSIS;
D O I
10.1111/j.1464-410X.2012.11050.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To describe how a family history of prostate cancer influences men's prostate cancer testing behaviours, information support preferences, and motives for testing. SUBJECTS AND METHODS Men with a fi rst-degree family history (239 men) and a comparison sample from the general population of Queensland, Australia (289) aged 40-65 years, and no prior history of cancer. Cross-sectional, retrospective survey assessing: prevalence of prostate-specifi c antigen (PSA) testing and digital rectal examination (DRE); discussion of prostate cancer risks and benefi ts with a physician; prostate cancer information needs and preferences; motivations for testing. RESULTS Men with a family history were more likely to report: having ever had a PSA test (odds ratio [OR] 4.98; 95% confi dence interval [CI] 3.16-7.85), more PSA tests in their lifetimes (b 1.04; SE 0.40; 95% CI 0.26-1.82); to have had a DRE (OR 2.23; 95% CI 1.54-3.23); to have spoken to a doctor about prostate cancer (OR 3.72; 95% CI 2.30-6.02); and to have instigated these discussions (OR 1.74; 95% CI 1.13-2.70). Most men from both groups did not recall any discussion of the ` cons ' of prostate cancer testing with a doctor. Men with a family history reported a greater desire for information about prostate cancer prevention than did men without a family history. CONCLUSIONS Men with a family history are more concerned about getting prostate cancer and are tested more often; however, information needs, discussions about prostate cancer, and motivations for testing are similar to those of all men. There appears to be a disparity between public health approaches that promote informed decision-making and what is happening in practice.
引用
收藏
页码:64 / 70
页数:7
相关论文
共 50 条
  • [1] Prostate cancer screening with Prostate-Specific Antigen (PSA) testing: A retrospective study
    Goktas, Olgun
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2024, 40 (10) : 2324 - 2330
  • [2] PROSTATE-SPECIFIC ANTIGEN (PSA)
    HOWANITZ, JH
    DISEASE MARKERS, 1993, 11 (01) : 3 - 10
  • [3] Association of sociodemographic factors and prostate-specific antigen (PSA) testing
    Gorday, William
    Sadrzadeh, Hossein
    de Koning, Lawrence
    Naugler, Christopher
    CLINICAL BIOCHEMISTRY, 2014, 47 (16-17) : 164 - 169
  • [4] Antiangiogenic properties of prostate-specific antigen (PSA)
    Mattsson, Johanna M.
    Laakkonen, Pirjo
    Stenman, Ulf-Hakan
    Koistinen, Hannu
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2009, 69 (04) : 447 - 451
  • [5] Prostate-specific antigen velocity (PSAV): a practical role for PSA?
    Thanigasalam, Ruban
    Mancuso, Pascal
    Tsao, Kim
    Rashid, Prem
    ANZ JOURNAL OF SURGERY, 2009, 79 (10) : 703 - 706
  • [6] The performance characteristics of prostate-specific antigen and prostate-specific antigen density in tOChinese men
    Teoh, Jeremy Y. C.
    Yuen, Steffi K. K.
    Tsu, James H. L.
    Wong, Charles K. W.
    Ho, Brian S. H.
    Ng, Ada T. L.
    Ma, Wai-Kit
    Ho, Kwan-Lun
    Yiu, Ming-Kwong
    ASIAN JOURNAL OF ANDROLOGY, 2017, 19 (01) : 113 - 116
  • [7] The influence of serial prostate-specific antigen (PSA) screening on the PSA velocity at diagnosis
    Martin, Neil E.
    Chen, Ming-Hui
    Catalona, William J.
    Loeb, Stacy
    Roehl, Kimberly A.
    D'Amico, Anthony V.
    CANCER, 2008, 113 (04) : 717 - 722
  • [8] Evaluating the influence of prostate-specific antigen kinetics on metastasis in men with PSA recurrence after partial gland therapy
    King, Martin T.
    Nguyen, Paul L.
    Boldbaatar, Ninjin
    Yang, David D.
    Muralidhar, Vinayak
    Tempany, Clare M.
    Cormack, Robert A.
    Hurwitz, Mark D.
    Suh, W. Warren
    Pomerantz, Mark M.
    D'Amico, Anthony V.
    Orio, Peter F., III
    BRACHYTHERAPY, 2019, 18 (02) : 198 - 203
  • [9] A "PSA Pyramid'' for Men with Initial Prostate-specific Antigen ≤3 ng/ml: A Plea for Individualized Prostate Cancer Screening
    Randazzo, Marco
    Beatrice, Josef
    Huber, Andreas
    Grobholz, Rainer
    Manka, Lukas
    Chun, Felix K.
    Recker, Franz
    Kwiatkowski, Maciej
    EUROPEAN UROLOGY, 2015, 68 (04) : 591 - 597
  • [10] The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States
    Legler, JM
    Feuer, EJ
    Potosky, AL
    Merrill, RM
    Kramer, BS
    CANCER CAUSES & CONTROL, 1998, 9 (05) : 519 - 527